RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
-14.02%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.99B
AUM Growth
-$1.53B
(-20%)
Cap. Flow
-$57.7M
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
62.92%
Holding
100
New
11
Increased
14
Reduced
4
Closed
15
Top Buys
| 1 |
Vaxcyte
PCVX
|
$132M |
| 2 |
SION
Sionna Therapeutics, Inc. Common Stock
SION
|
$109M |
| 3 |
Disc Medicine
IRON
|
$78.3M |
| 4 |
Geron
GERN
|
$48.3M |
| 5 |
89bio
ETNB
|
$41.5M |
Top Sells
| 1 |
Legend Biotech
LEGN
|
$244M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$111M |
| 3 |
Axsome Therapeutics
AXSM
|
$84.6M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$82.1M |
| 5 |
Praxis Precision Medicines
PRAX
|
$58.6M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Adicet Bio
ACET
$60M
| $5.69M | 0.1% |
7,541,000
| – | – |
|
77
Humacyte
HUMA
$226M
| $5.65M | 0.09% |
+3,312,356
| New | +$5.65M |
|
78
Zura Bio
ZURA
$143M
| $4.15M | 0.07% |
3,217,503
| – | – |
|
|
BIOA
79
BioAge Labs, Inc. Common Stock
BIOA
$171M
| $3.96M | 0.07% |
1,052,494
-258,095
| -20% | -$970K |
|
|
BOLD
80
Boundless Bio
BOLD
$25.7M
| $3.29M | 0.06% |
2,180,631
| – | – |
|
81
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$71.3M
| $3M | 0.05% |
333,333
| – | – |
|
82
Sutro Biopharma
STRO
$89.9M
| $2.89M | 0.05% |
+4,434,637
| New | +$2.89M |
|
83
Lexeo Therapeutics
LXEO
$271M
| $1.9M | 0.03% |
546,554
| – | – |
|
84
CytomX Therapeutics
CTMX
$376M
| $636K | 0.01% |
+1,000,000
| New | +$636K |
|
85
Scilex Holding
SCLX
$159M
| $258K | ﹤0.01% |
29,606
| – | – |
|
|
ALLK
86
DELISTED
Allakos
ALLK
| – | – |
-1,129,931
| Closed | -$1.37M |
|
87
Arvinas
ARVN
$575M
| – | – |
-421,348
| Closed | -$8.08M |
|
|
88
Axsome Therapeutics
AXSM
$6.25B
| – | – |
-1,000,000
| Closed | -$84.6M |
|
89
C4 Therapeutics
CCCC
$194M
| – | – |
-4,878,000
| Closed | -$17.6M |
|
90
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-1,038,000
| Closed | -$5.97M |
|
91
Evolent Health
EVH
$1.11B
| – | – |
-3,577,197
| Closed | -$40.2M |
|
|
92
Legend Biotech
LEGN
$6.66B
| – | – |
-7,506,934
| Closed | -$244M |
|
93
Pliant Therapeutics
PLRX
$114M
| – | – |
-1,281,000
| Closed | -$16.9M |
|
|
94
Praxis Precision Medicines
PRAX
$986M
| – | – |
-761,955
| Closed | -$58.6M |
|
|
RGLS
95
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-336,843
| Closed | -$532K |
|
96
Recursion Pharmaceuticals
RXRX
$2.01B
| – | – |
-7,725,096
| Closed | -$52.2M |
|
|
THRD
97
DELISTED
Third Harmonic Bio
THRD
| – | – |
-960,620
| Closed | -$9.88M |
|
|
VRNA
98
Verona Pharma
VRNA
$9.2B
| – | – |
-1,766,830
| Closed | -$82.1M |
|
|
99
SPDR S&P Biotech ETF
XBI
$5.39B
| – | – |
-1,228,240
| Closed | -$111M |
|
|
CMRX
100
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-8,800,000
| Closed | -$30.6M |
|